How to Fast-Track Large Scale Investments Through an Early, Integrated Approach

The pharma industry demands rapid, local-for-local investments to counter supply chain bottlenecks and support both innovation scale-up and standard production for individual markets. Factory capabilities now directly influence inventory levels and supply chain responsiveness, making strategic site planning and fast-track investments essential.

At the same time, manufacturers face mounting challenges: complex definition of user requirements, lengthy stakeholder alignment, and fragmented responsibilities in traditional EPCM models.

Addressing these challenges with an integrated approach is key — engaging in the earliest stage of manufacturing footprint design already functional and execution expertise, a structured requirements gathering, and extensive benchmark costing enables a significantly shortened realization period. The proposed model accelerates decision-making, reduces complexity, and delivers future-ready facilities that strengthen resilience and market agility.